Results 201 to 210 of about 177,876 (307)

Tissue degrading and remodelling molecules in giant cell arteritis. [PDF]

Rheumatology (Oxford)
Watanabe N, Hara Y, Nishito Y, Kounoe M, Sekiyama K, Takamasu E, Kise T, Chinen N, Shimada K, Sugihara M, Kawaji H.   +10 more
europepmc   +1 more source

Giant cell arteritis presenting with peripheral neuropathy

, 1984
Fiona Mulcahy, L D Juby, G.N. Chandler
openalex   +1 more source

Giant cell arteritis and thyroid dysfunction: multicentre case-control study [PDF]

, 1999
P. Duhaut, H Bornet, L. Pinède, S. Demolombe-Rague, R Loire, D. Seydoux, J. Ninet, J. Pasquier   +7 more
openalex   +1 more source

Ocular ischaemic syndrome due to giant cell arteritis. [PDF]

BMJ Case Rep
Wilkinson EC, McLucas M, Ayton T, Dunlop A.   +3 more
europepmc   +1 more source

The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

, 1983
M E Ellis, S. Ralston
openalex   +1 more source

Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: A systematic literature review.

Seminars in Arthritis & Rheumatism, 2020
Ankita Sharma, A. Mohammad, C. Turesson
semanticscholar   +1 more source

Biomarkers of ocular manifestation in newly diagnosed giant cell arteritis. [PDF]

BMC Ophthalmol
Terheyden JH, Petzinna SM, Burg LC, von der Emde L, Behning C, Jungblut J, Reinking K, Holz FG, Ach T, Wintergerst MWM, Schäfer VS, Finger RP.   +11 more
europepmc   +1 more source

Giant Cell Arteritis [PDF]

Acta Medica Scandinavica, 1982
openaire   +3 more sources

Polymyalgia Rheumatica and Giant Cell Arteritis: A Geriatric Perspective. [PDF]

Cureus
Muhammad A, Kakar ZH, Farooq M, Roohani MU, Bibi Z, Elgorashi K, Ahmad S, Ali J, Sami N.   +8 more
europepmc   +1 more source

Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis? [PDF]

, 1996
M. J. van der Veen, Huibert J. Dinant, C van Booma-Frankfort, G A van Albada-Kuipers, J. W. J. Bijlsma   +4 more
openalex   +1 more source